Literature DB >> 9539267

Pre-exposure of rats to amphetamine sensitizes self-administration of this drug under a progressive ratio schedule.

A Mendrek1, C D Blaha, A G Phillips.   

Abstract

Two groups of male rats were tested to determine whether pre-exposure to d-amphetamine would enhance the motivation to self-administer the drug under a progressive ratio schedule of reinforcement. In the first phase of the experiment, one group of rats received d-amphetamine (2 mg/kg IP), while a second group received saline on alternate days for a total of ten injections. Following a 21-day drug withdrawal period, behavioral sensitization was confirmed by a significant increase in amphetamine-induced stereotypy in the d-amphetamine-pretreated group, relative to the saline-pretreated group. In the second phase of the study, all rats were implanted with chronic jugular catheters and trained to self-administer d-amphetamine (0.2 mg/kg per infusion) under a fixed-ratio schedule of reinforcement. The progressive ratio paradigm was then imposed for 7 consecutive days; d-amphetamine-pretreated rats attained significantly higher break points than saline-pretreated animals. These data suggest that pre-exposure to d-amphetamine may enhance the motivation to self-administer this drug.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9539267     DOI: 10.1007/s002130050530

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  50 in total

1.  Striatal cell type-specific overexpression of DeltaFosB enhances incentive for cocaine.

Authors:  Christina R Colby; Kim Whisler; Cathy Steffen; Eric J Nestler; David W Self
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

2.  A progressive ratio schedule of self-stimulation testing in rats reveals profound augmentation of d-amphetamine reward by food restriction but no effect of a "sensitizing" regimen of d-amphetamine.

Authors:  Soledad Cabeza de Vaca; Lisa L Krahne; Kenneth D Carr
Journal:  Psychopharmacology (Berl)       Date:  2004-02-20       Impact factor: 4.530

Review 3.  Motivational Processes Underlying Substance Abuse Disorder.

Authors:  Paul J Meyer; Christopher P King; Carrie R Ferrario
Journal:  Curr Top Behav Neurosci       Date:  2016

4.  Sensitization of the reinforcing effects of self-administered cocaine in rats: effects of dose and intravenous injection speed.

Authors:  Yu Liu; David C S Roberts; Drake Morgan
Journal:  Eur J Neurosci       Date:  2005-07       Impact factor: 3.386

5.  The sensitizing effect of acute nicotine on amphetamine-stimulated behavior and dopamine efflux requires activation of β2 subunit-containing nicotinic acetylcholine receptors and glutamate N-methyl-D-aspartate receptors.

Authors:  Myung N Kim; Emily M Jutkiewicz; Minjia Zhang; Margaret E Gnegy
Journal:  Neuropharmacology       Date:  2010-10-28       Impact factor: 5.250

Review 6.  AMPA receptor plasticity in the nucleus accumbens after repeated exposure to cocaine.

Authors:  Marina E Wolf; Carrie R Ferrario
Journal:  Neurosci Biobehav Rev       Date:  2010-01-28       Impact factor: 8.989

Review 7.  Drug wanting: behavioral sensitization and relapse to drug-seeking behavior.

Authors:  Jeffery D Steketee; Peter W Kalivas
Journal:  Pharmacol Rev       Date:  2011-04-13       Impact factor: 25.468

8.  Increased breakpoints on a progressive ratio schedule reinforced by IV cocaine are associated with reduced locomotor activation and reduced dopamine efflux in nucleus accumbens shell in rats.

Authors:  Christopher M Lack; Sara R Jones; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2007-09-19       Impact factor: 4.530

9.  Stress and Rodent Models of Drug Addiction: Role of VTA-Accumbens-PFC-Amygdala Circuit.

Authors:  Jasmine J Yap; Klaus A Miczek
Journal:  Drug Discov Today Dis Models       Date:  2008

10.  Binge self-administration and deprivation produces sensitization to the reinforcing effects of cocaine in rats.

Authors:  Drake Morgan; Mark A Smith; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2004-08-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.